Formyl Peptide Receptor 3 (FPR3) Antibody (HRP)

Este producto es parte de FPR - Formyl Peptide Receptor
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Formyl Peptide Receptor 3 (FPR3) Antibody (HRP)
category
Primary Antibodies
provider
Abbexa
reference
abx336811
tested applications
ELISA

Description

FPR3 Antibody (HRP) is a Rabbit Polyclonal against FPR3.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetFormyl Peptide Receptor 3 (FPR3)
HostRabbit
ReactivityHuman
Recommended DilutionOptimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationHRP
IsotypeIgG
Purity> 95%
PurificationPurified by Protein G.
Size 120 µg
Size 250 µg
Size 3100 µg
Size 4200 µg
Size 51 mg
FormLiquid
Tested ApplicationsELISA
Buffer0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDP25089
Gene ID2359
AliasFPR3,FMLPY,FPRH1,FPRL2,Fprl1 ,Lxa4r,LXA4-R,FPRH2,RMLP-R-I,FMLP-R-II,FML2_HUMAN
BackgroundAntibody anti-FPR3
StatusRUO

Descripción

FPR3 is a G protein-coupled receptor expressed primarily on monocytes, dendritic cells, and lymphocytes, where it contributes to immune regulation and inflammation. Unlike FPR1 and FPR2, FPR3 has lower affinity for formylated peptides and is more associated with endogenous ligands, playing a role in immune cell migration and immune surveillance. FPR3 localizes primarily to intracellular compartments, suggesting a role in regulating immune responses through intracellular signaling and peptide degradation. It modulates chemotactic responses, dendritic cell maturation, and cytokine production, balancing pro-inflammatory and homeostatic functions. Dysregulation of FPR3 signaling has been implicated in immune disorders and chronic inflammation, where impaired immune cell trafficking can lead to dysfunctional responses. In cancer, FPR3 may contribute to immune evasion and tumor progression, although its role remains less defined compared to FPR1 and FPR2. Targeting FPR3 offers potential for therapies aimed at fine-tuning immune responses, particularly in conditions involving inflammation and immune regulation. Overall, FPR3 acts as a modulator of immune cell function and homeostasis.

Related Products

abx015243

Formyl Peptide Receptor-Like 2 (FPRL2) Antibody

Rabbit polyclonal antibody against FPRL2 protein. Immunogen region is C-terminal.

Ver Producto
abx027122

Formyl Peptide Receptor 3 (FPR3) Antibody

Low affinity receptor for N-formyl-methionyl peptides, which are powerful neutrophils chemotactic factors. Binding of FMLP to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system.

Ver Producto
abx034108

Formyl Peptide Receptor-Like 2 (FPRL2) Antibody

Low affinity receptor for N-formyl-methionyl peptides, which are powerful neutrophils chemotactic factors. Binding of FMLP to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system.

Ver Producto